通策医疗
(600763)
| 流通市值：181.51亿 | | | 总市值：181.51亿 |
| 流通股本：4.47亿 | | | 总股本：4.47亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 597,368,979.92 | 620,555,167.34 | 597,943,865.14 | 623,136,698.67 |
| 应收票据及应收账款 | 181,705,583.16 | 151,025,182.2 | 151,639,601.28 | 151,559,931.34 |
| 应收账款 | 181,705,583.16 | 151,025,182.2 | 151,639,601.28 | 151,559,931.34 |
| 预付款项 | 14,332,601.29 | 12,277,848.25 | 15,461,050.61 | 15,403,501.28 |
| 其他应收款合计 | 80,486,944.86 | 74,880,996.75 | 77,424,023 | 72,862,327.03 |
| 应收股利 | 38,958,904.11 | 36,000,000 | 32,942,465.75 | 29,950,684.93 |
| 存货 | 28,644,144.32 | 29,988,974.38 | 23,532,259.52 | 25,231,500.25 |
| 其他流动资产 | 31,737,147.37 | 27,484,059.5 | 24,284,020.21 | 21,401,566.75 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 935,692,569.16 | 917,629,396.66 | 890,284,819.76 | 909,595,525.32 |
| 非流动资产: | | | | |
| 长期股权投资 | 932,998,563.82 | 924,587,958.72 | 918,604,908.12 | 914,039,747.85 |
| 其他权益工具投资 | 218,462,732.86 | 222,608,305.54 | 363,554,288.98 | 364,342,969.4 |
| 投资性房地产 | 39,460,333.36 | 39,830,253.97 | 40,200,174.58 | 40,570,095.19 |
| 固定资产 | 791,740,910.69 | 796,079,254.18 | 815,758,051.19 | 829,635,877.03 |
| 在建工程 | 1,085,449,484.91 | 1,030,460,244.51 | 1,061,059,999.47 | 993,044,433.76 |
| 使用权资产 | 1,040,771,114.51 | 1,064,794,518.94 | 1,044,745,231.42 | 1,048,306,273.09 |
| 无形资产 | 78,638,283.39 | 79,679,850.32 | 13,707,082.55 | 13,927,510.32 |
| 商誉 | 73,055,428.94 | 73,055,428.94 | 73,055,428.94 | 73,055,428.94 |
| 长期待摊费用 | 395,082,242.34 | 389,844,919.96 | 364,007,913.16 | 367,438,017.29 |
| 递延所得税资产 | 58,571,059.34 | 61,501,102.52 | 23,679,251.95 | 25,458,639.73 |
| 其他非流动资产 | 613,449,363.99 | 582,017,408.13 | 615,152,019.34 | 572,575,253.1 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 5,327,679,518.15 | 5,264,459,245.73 | 5,333,524,349.7 | 5,242,394,245.7 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 6,263,372,087.31 | 6,182,088,642.39 | 6,223,809,169.46 | 6,151,989,771.02 |
| 流动负债: | | | | |
| 短期借款 | - | 80,089,205.48 | 80,000,000 | 80,000,000 |
| 应付票据及应付账款 | 128,439,580.55 | 136,650,854.56 | 166,830,046.08 | 164,380,383.6 |
| 应付账款 | 128,439,580.55 | 136,650,854.56 | 166,830,046.08 | 164,380,383.6 |
| 预收款项 | 389,245.93 | 110,784.46 | 149,520.98 | 236,851.05 |
| 合同负债 | 10,644,921.32 | 19,817,991.51 | 10,962,142.13 | 11,906,730.85 |
| 应付职工薪酬 | 12,555,784.59 | 39,474,780.64 | 8,300,807.58 | 8,800,781.89 |
| 应交税费 | 104,317,511.51 | 109,478,603.1 | 66,454,344.84 | 46,778,742.54 |
| 其他应付款合计 | 31,675,645.81 | 32,204,833.92 | 27,085,193.43 | 217,643,348.84 |
| 应付股利 | 7,116,472.58 | 7,116,472.58 | - | 190,867,241.68 |
| 一年内到期的非流动负债 | 294,914,321.86 | 129,441,576.57 | 121,675,826.3 | 113,018,585.26 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 582,937,011.57 | 547,268,630.24 | 481,457,881.34 | 642,765,424.03 |
| 非流动负债: | | | | |
| 长期借款 | - | 169,000,000 | 179,000,000 | 179,000,000 |
| 租赁负债 | 1,069,292,312.92 | 1,065,473,974.86 | 1,026,146,204.07 | 1,026,690,845.45 |
| 递延收益 | 13,998,864.66 | 14,378,230.14 | 14,737,595.62 | 15,146,961.1 |
| 递延所得税负债 | 23,051,526.3 | 26,878,231.42 | 25,236,374.96 | 25,332,646.63 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 1,106,342,703.88 | 1,275,730,436.42 | 1,245,120,174.65 | 1,246,170,453.18 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 1,689,279,715.45 | 1,822,999,066.66 | 1,726,578,055.99 | 1,888,935,877.21 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 447,289,117 | 447,289,117 | 447,289,117 | 319,356,500 |
| 其他综合收益 | -95,015,711.68 | -95,015,711.61 | 6,655,852.38 | 6,655,852.38 |
| 盈余公积 | 25,413,088.99 | 27,509,029.95 | - | - |
| 未分配利润 | 3,831,940,778.35 | 3,648,015,764.74 | 3,672,497,634.18 | 3,611,971,288.26 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 4,209,627,272.66 | 4,027,798,200.08 | 4,126,442,603.56 | 3,937,983,640.64 |
| 少数股东权益 | 364,465,099.19 | 331,291,375.65 | 370,788,509.92 | 325,070,253.17 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 4,574,092,371.85 | 4,359,089,575.73 | 4,497,231,113.48 | 4,263,053,893.81 |
| 负债和股东权益合计 | 6,263,372,087.3 | 6,182,088,642.39 | 6,223,809,169.47 | 6,151,989,771.02 |
| 公告日期 | 2025-04-26 | 2025-04-26 | 2024-10-29 | 2024-08-24 |
| 审计意见(境内) | | 标准无保留意见 | | |